Establishment of human iPS cells differentiation from TOF

Establishment of human iPS cells differentiation from TOF - Establishment of human iPS cells differentiation from TOF

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031786

Enrollment

Registered

2018-04-04

Start date

2018-04-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tetralogy of fallot

Interventions

Genome analysis, epigenome analysis, DNA damage and cardiomyocyte differentiation induction analysis and quality assessment using human iPS cells in tetralogy of fallot. Genome analysis, epigenome ana

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergone pediatric cardiac surgery, and be dissected thymus tissue as a residual specimen, and taken written consent to this study.

Exclusion criteria

Exclusion criteria: Patients who were unable to take consent to this study in writing.

Design outcomes

Primary

Measure	Time frame
Comparison of genome analysis, epigenome analysis, DNA damage and cardiomyocyte differentiation induction analysis and quality assessment using human iPS cells in tetralogy of Fallot and other congenital heart diseases.	—

Countries

Japan

Contacts

Public ContactRyusuke Hosoda

Saitama medical university International medical Center Pediatric cardiac surgeon

medicaryu@live.jp042-984-4111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026